|
|
|
|
|
|
Aurinia Pharm Ord (AUPH)
|
|
6.10 -0.01 (-0.16%)
|
8/18/2017 4:00pm
|
|
Open:
|
6.10
|
Pre. Close:
|
6.11
|
|
High:
|
6.19
|
Low:
|
6.01
|
|
Volume:
|
579,843
|
Market Cap:
|
509.26M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
6.32 - 6.34
|
6.34 - 6.35
|
|
Low:
|
5.83 - 5.87
|
5.87 - 5.9
|
|
Close:
|
6.04 - 6.14
|
6.14 - 6.2
|
|
|
|
|
|
|
Technical analysis (as of: 2017-08-18 4:35:09 PM)
|
|
Overall:
|
|
|
Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.
|
|
Target:
|
Six months: 8.07 One year: 8.97
|
|
Support:
|
Support1: 5.66 Support2: 4.71
|
|
Resistance:
|
Resistance1:
6.91 Resistance2: 7.68
|
|
Pivot:
|
6.10 
|
|
Moving Averages:
|
MA(5): 6.16  MA(20): 6.18
MA(100): 6.61 MA(250): 4.76
|
|
MACD:
|
MACD(12,26):
-0.08 Signal(12,26,9): -0.09
|
|
%K %D:
|
%K(14,3): 59.88 %D(3): 58.05
|
|
RSI:
|
RSI(14): 46.28
|
|
52-Week:
|
High: 10.54
Low: 1.88 Change(%): 181.1
|
|
Average Vol(K):
|
3-Month: 154588
10-Days 42229
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.AUPH has closed below upper band by 49.4%. Bollinger Bands are 50.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to AUPH's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
Tue, 28 Mar 2017 13:34:19 GMT
Aurinia Pharmaceuticals: Highlighting An Important Clinical And Regulatory Change
Tue, 14 Mar 2017 20:03:45 GMT
Aurinia Pharmaceuticals: All Systems Go
Fri, 24 Mar 2017 13:53:27 GMT
Aurinia Pharmaceuticals: Fully Funded With Upcoming Catalysts
Mon, 01 May 2017 13:57:07 GMT
Aurinia Pharmaceuticals Is A Top Pick For H2 2017
Mon, 06 Mar 2017 22:41:15 GMT
Why Is Aurinia Pharmaceuticals A Definite Buy In 2017?
|
|
|
Financial Analysis
|
|
Growth
|
NA
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
NA
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
NA
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
